Civic AI
Procurement intelligence
Federal contract award
INHALED ANTI-MUSCARINIC AGENTS AS CONTINGENCY MCMS AGAINST NERVE AGENT-INDUCED BRONCHORRHEA SUPPLEMENTAL FUNDING DUE TO HIGHER THAN EXPECTED MODEL DEVELOPMENT COSTS, NECESSARY TO COMPLETE THE REMAINING MCM EFFICACY STUDY TASK. PREVIOUS OBLIGATE
BATTELLE MEMORIAL INSTITUTE · Department of Health and Human Services
- Value
- $3,581,970
- Start
- Sep 23, 2022
- End
- Sep 30, 2024
- Action date
- Jan 20, 2026
- PIID
- 75A50122F61001
- Status
- completed
- NAICS
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- Place of performance
- COLUMBUS, OH
- Award type
- DELIVERY ORDER
Description
INHALED ANTI-MUSCARINIC AGENTS AS CONTINGENCY MCMS AGAINST NERVE AGENT-INDUCED BRONCHORRHEA SUPPLEMENTAL FUNDING DUE TO HIGHER THAN EXPECTED MODEL DEVELOPMENT COSTS, NECESSARY TO COMPLETE THE REMAINING MCM EFFICACY STUDY TASK. PREVIOUS OBLIGATE
Need modifications, related awards, and vendor peers? Open the full award workspace.